Clinical Cancer Research, Vol 3, Issue 1 3-9, Copyright © 1997 by American Association for Cancer Research

ARTICLES

Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma

W Xia, YK Lau, HZ Zhang, AR Liu, L Li, N Kiyokawa, GL Clayman, RL Katz and MC Hung
Department of Tumor Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

Overexpression of c-erbB-2 (also known as HER-2/neu) has been found in many human cancers, including head and neck squamous cell carcinoma (SCC). We therefore examined expression of the oncoprotein in oral SCC primary tumor samples and compared its relationship with clinical stages and survival rate. Out of 80 cases of oral SCC, high expression level (++ or +++) of c-erbB-2 was found in 41 cases. Of the 80 cases with follow-up information, 39 were further investigated for the correlation of expression level of c-erbB-2 and survival rate. Overexpression of the oncoprotein was significantly correlated with shorter overall survival, and the patients with low and no expression of c-erbB-2 had much higher survival rates. Overexpression of c-erbB-2 was also significantly correlated with nodal stage and metastasis. We found that high expression level of c-erbB-2 was frequently detected in oral cancer cell lines but not in the other head and neck SCC cell lines. Thus, we conclude that overexpression of c-erbB-2 is a frequent event in oral SCC and is correlated with poor survival and may be used as a poor prognostic factor.

This article has been cited by other articles:

				S. Choi and J.N. Myers Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy J. Dent. Res., January 1, 2008; 87(1): 14 - 32. [Abstract] [Full Text] [PDF]

				W. Xia, J.-S. Chen, X. Zhou, P.-R. Sun, D.-F. Lee, Y. Liao, B. P. Zhou, and M.-C. Hung Phosphorylation/Cytoplasmic Localization of p21Cip1/WAF1 Is Associated with HER2/neu Overexpression and Provides a Novel Combination Predictor for Poor Prognosis in Breast Cancer Patients Clin. Cancer Res., June 1, 2004; 10(11): 3815 - 3824. [Abstract] [Full Text] [PDF]

				M. E. Wolpoe, E. R. Lutz, A. M. Ercolini, S. Murata, S. E. Ivie, E. S. Garrett, L. A. Emens, E. M. Jaffee, and R. T. Reilly HER-2/neu-Specific Monoclonal Antibodies Collaborate with HER-2/neu-Targeted Granulocyte Macrophage Colony-Stimulating Factor Secreting Whole Cell Vaccination to Augment CD8+ T Cell Effector Function and Tumor-Free Survival in Her-2/neu-Transgenic Mice J. Immunol., August 15, 2003; 171(4): 2161 - 2169. [Abstract] [Full Text] [PDF]

				C. J. Piyathilake, A. R. Frost, U. Manne, H. Weiss, W. C. Bell, D. C. Heimburger, and W. E. Grizzle Differential Expression of Growth Factors in Squamous Cell Carcinoma and Precancerous Lesions of the Lung Clin. Cancer Res., March 1, 2002; 8(3): 734 - 744. [Abstract] [Full Text] [PDF]

				S. A. Alhasan, O. Aranha, and F. H. Sarkar Genistein Elicits Pleiotropic Molecular Effects on Head and Neck Cancer Cells Clin. Cancer Res., December 1, 2001; 7(12): 4174 - 4181. [Abstract] [Full Text] [PDF]

				G. N. Hortobagyi, N. T. Ueno, W. Xia, S. Zhang, J. K. Wolf, J. B. Putnam, P. L. Weiden, J. S. Willey, M. Carey, D. L. Branham, et al. Cationic Liposome-Mediated E1A Gene Transfer to Human Breast and Ovarian Cancer Cells and Its Biologic Effects: A Phase I Clinical Trial J. Clin. Oncol., July 15, 2001; 19(14): 3422 - 3433. [Abstract] [Full Text] [PDF]

				F. Xu, W. Xia, R. Z. Luo, H. Peng, S. Zhao, J. Dai, Y. Long, L. Zou, W. Le, J. Liu, et al. The Human ARHI Tumor Suppressor Gene Inhibits Lactation and Growth in Transgenic Mice Cancer Res., September 1, 2000; 60(17): 4913 - 4920. [Abstract] [Full Text]

				W. Xia, Y.-K. Lau, H.-Z. Zhang, F.-Y. Xiao, D. A. Johnston, A.-R. Liu, L. Li, R. L. Katz, and M.-C. Hung Combination of EGFR, HER-2/neu, and HER-3 Is a Stronger Predictor for the Outcome of Oral Squamous Cell Carcinoma Than Any Individual Family Members Clin. Cancer Res., December 1, 1999; 5(12): 4164 - 4174. [Abstract] [Full Text] [PDF]

				L. Zhang, Y.-K. Lau, W. Xia, G. N. Hortobagyi, and M.-C. Hung Tyrosine Kinase Inhibitor Emodin Suppresses Growth of HER-2/neu-overexpressing Breast Cancer Cells in Athymic Mice and Sensitizes These Cells to the Inhibitory Effect of Paclitaxel Clin. Cancer Res., February 1, 1999; 5(2): 343 - 353. [Abstract] [Full Text] [PDF]

				L. Y. W. Bourguignon, H. Zhu, A. Chu, N. Iida, L. Zhang, and M.-C. Hung Interaction between the Adhesion Receptor, CD44, and the Oncogene Product, p185HER2, Promotes Human Ovarian Tumor Cell Activation J. Biol. Chem., October 31, 1997; 272(44): 27913 - 27918. [Abstract] [Full Text] [PDF]